Since our first preclinical study published in 2004, identifying increased galectin-3 expression in cardiac fibrosis [35], and the first clinical study published in 2006 showing increased circulating galectin-3 in heart failure [39], several other groups have reported an association between galectin-3 expression and cardiac remodeling, heart failure, and death. This evidence concerns the gene LGALS3 and heart failure.